Fort Washington Investment Advisors’s GSK GSK Stock Holding History

Fort Washington Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-35,040	Closed	-$1.82M	–	456
2015 Q2	$1.82M	Buy	35,040 +640	+2%	+$36K	0.03%	209
2015 Q1	$1.98M	Hold	34,400	–	–	0.04%	205
2014 Q4	$1.84M	Hold	34,400	–	–	0.04%	213
2014 Q3	$1.98M	Hold	34,400	–	–	0.04%	208
2014 Q2	$2.3M	Buy	34,400 +480	+1%	+$32.5K	0.04%	214
2014 Q1	$2.27M	Hold	33,920	–	–	0.05%	198
2013 Q4	$2.26M	Buy	33,920 +80	+0.2%	+$5.19K	0.05%	244
2013 Q3	$2.12M	Hold	33,840	–	–	0.05%	261
2013 Q2	$2.11M	Buy	+33,840	New	+$2.15M	0.05%	260

Other funds holding GSK

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fort Washington Investment Advisors's GSK Position: Q3 2015 in Review

Fort Washington Investment Advisors sold out of GSK (GSK) in Q3 2015, closing a stake of 35,040 shares — an estimated $1.82M sold.

Fort Washington Investment Advisors first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $2.3M in Q2 2014. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

Fort Washington Investment Advisors reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
Fort Washington Investment Advisors sold 35,040 GSK shares in Q3 2015, an estimated $1.82M.
Fort Washington Investment Advisors first reported a position in GSK in Q2 2013 and held it in 9 quarters.
Fort Washington Investment Advisors's GSK position peaked at $2.3M in Q2 2014.
706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Fort Washington Investment Advisors's 13F filing for Q3 2015, filed 9 Nov 2015.